Automated 3D-printing of personalized medicines for pharmacies
| Date | Round | Amount |
|---|---|---|
| Jul 2026 | Series A CurifyLabs closed a 12 million euro Series A to expand US operations and its 3D-printing-based medicine compounding platform. The round was co-led by Sandwater and HealthCap with Tesi and existing investors including Lifeline Ventures. | $14M |
| Mar 2023 | Grant Helsinki healthtech CurifyLabs received a EUR2.5M EIC Accelerator grant for its personalized-medicine MiniLab. | $2.7M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.